The West Virginia University Rockefeller Neuroscience Institute (RNI), WVU Medicine, and Oura Health today announced a national study designed to accelerate early detection of the COVID-19 virus symptoms. RNI scientists and partners are developing an innovative “digital PPE” approach that potentially can identify infected frontline healthcare professionals before they become symptomatic – a possible breakthrough in monitoring capabilities and limiting the spread.
Over the past three weeks, Oura rings and the RNI COVID-19 monitoring smartphone app have been deployed to physicians, nurses, and other frontline healthcare workers in the ED, ICU, testing sites, and urgent care settings in West Virginia. In addition, the RNI is partnering with hospitals across the country, including those in New York City, Philadelphia, Nashville, and other critical emerging areas, to monitor more than 1,000 front-line healthcare personnel with exposure to COVID-19.
“We are continuously monitoring the mind-body connectivity through our integrated neuroscience platform measuring the autonomic nervous system, fatigue, anxiety, circadian rhythms, and other human resilience and recovery functions,” Ali Rezai, M.D., executive chair of the WVU Rockefeller Neuroscience Institute, said. “Our AI-driven models are currently predicting symptoms 24 hours prior to onset, and we are working toward a three-plus day forecast. This forecasting capability will help us get ahead of this pandemic; limit the spread to protect healthcare workers, their families, and our communities; and improve our understanding of health recovery.”
“We have done extensive research in the wearable space, and Oura’s accuracy and usability is unparalleled to anything we have tested,” added Dr. Rezai, “We are proud to partner with Oura and its innovation to serve our population.”
Oura ring products and services are not medical devices, and are not intended to mitigate, prevent, treat, cure or diagnose any disease or condition. If you have any concerns about your health, please consult your doctor.
For more information please see the full press release.